Evidence map›Paper›PMID 35203671›Full record

ArticleBiomedicines2022

Synthesis, Structure, and Antiproliferative Action of 2-Pyridyl Urea-Based Cu(II) Complexes.

Kirill K Geyl, Sergey V Baykov, Stanislav A Kalinin, Alexandr S Bunev, Marina A Troshina, Tatiana V Sharonova, Mikhail Yu Skripkin, Svetlana O Kasatkina, Sofia I Presnukhina, Anton A Shetnev and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Synthesis of 3-(Pyridin-2-yl)quinazolin-2,4(1International journal of molecular sciences · 2023
    Article
  3. Room Temperature Synthesis of Bioactive 1,2,4-Oxadiazoles.International journal of molecular sciences · 2023
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Kirill K GeylInstitute of Chemistry, Saint Petersburg State University, 199034 Saint Petersburg, Russia.
Sergey V BaykovInstitute of Chemistry, Saint Petersburg State University, 199034 Saint Petersburg, Russia.ORCID 0000-0002-8912-5816
Stanislav A KalininInstitute of Chemistry, Saint Petersburg State University, 199034 Saint Petersburg, Russia.ORCID 0000-0002-6421-1208
Alexandr S BunevMedicinal Chemistry Center, Togliatti State University, 445020 Togliatti, Russia.ORCID 0000-0001-6408-8329
Marina A TroshinaMedicinal Chemistry Center, Togliatti State University, 445020 Togliatti, Russia.
Tatiana V SharonovaInstitute of Chemistry, Saint Petersburg State University, 199034 Saint Petersburg, Russia.
Mikhail Yu SkripkinInstitute of Chemistry, Saint Petersburg State University, 199034 Saint Petersburg, Russia.ORCID 0000-0001-9841-150X
Svetlana O KasatkinaInstitute of Chemistry, Saint Petersburg State University, 199034 Saint Petersburg, Russia.
Sofia I PresnukhinaInstitute of Chemistry, Saint Petersburg State University, 199034 Saint Petersburg, Russia.
Anton A ShetnevPharmaceutical Technology Transfer Center, Yaroslavl State Pedagogical University Named after K.D. Ushinsky, 150000 Yaroslavl, Russia.ORCID 0000-0002-4389-461X
Mikhail Yu KrasavinInstitute of Chemistry, Saint Petersburg State University, 199034 Saint Petersburg, Russia.ORCID 0000-0002-0200-4772
Vadim P BoyarskiyInstitute of Chemistry, Saint Petersburg State University, 199034 Saint Petersburg, Russia.ORCID 0000-0002-6038-0872
St Petersburg University · RUTogliatti State University · RUYaroslavl State Pedagogical University · RU

Funding

Russian Science Foundation 20-73-00038
6 · The paper itself

Abstract

Relying on a recently suggested protocol that furnishes convenient access to variously substituted 2-pyridyl ureas, twelve hitherto unknown Cu(II) complexes have been synthesized in the present work and their structures were evaluated by elemental analysis, HRMS, IR spectroscopy, and X-ray diffraction study. Two structural motifs ([Cu(L)

Indexed as

anti-cancer drugscytotoxicitylung cancermetal complexesureas

Identifiers

PMID35203671
PMCPMC8962293
OpenAlexW4212957145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.